Number of the records: 1
Genomic Confirmation of Borrelia garinii, United States
- 1.0567729 - BC 2024 RIV US eng J - Journal Article
Rudenko, Natalia - Golovchenko, Maryna - Horák, Aleš - Grubhoffer, Libor - Mongodin, E.F. - Fraser, C.M. - Qiu, W. - Luft, B. J. - Morgan, R.G. - Casjens, S.R. - Schutzer, S. E.
Genomic Confirmation of Borrelia garinii, United States.
Emerging Infectious Diseases. Roč. 29, č. 1 (2023), s. 64-69. ISSN 1080-6040. E-ISSN 1080-6059
R&D Projects: GA MZd(CZ) NV19-05-00191; GA ČR(CZ) GA21-26209S
Institutional support: RVO:60077344
Keywords : Genomic * Borrelia garinii * United States
OECD category: Immunology
Impact factor: 11.8, year: 2022
Method of publishing: Limited access
https://wwwnc.cdc.gov/eid/article/29/1/22-0930_article
Lyme disease is a multisystem disorder primarily caused by Borrelia burgdorferi sensu lato. However, B. garinii, which has been identified on islands off the coast of New-foundland and Labrador, Canada, is a cause of Lyme dis-ease in Eurasia. We report isolation and whole-genome nucleotide sequencing of a B. garinii isolate from a cot-ton mouse (Peromyscus gossypinus) in South Carolina, USA. We identified a second B. garinii isolate from the same repository. Phylogenetic analysis does not associ-ate these isolates with the previously described isolates of B. garinii from Canada.
Permanent Link: https://hdl.handle.net/11104/0344204
Number of the records: 1